MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan · Delayed Price · Currency is TWD 13.85
+0.20 (1.47%)
Oct 8, 2026, 2:58 PM CST
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 896.38 million as of October 9, 2026. It is the 34,642nd most valuable company in the world and the 2,097th biggest in Taiwan. Its market cap has decreased by 7.67% in one year.
Market Cap
896.38M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,097 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 896.38M, a decrease of -57.58%. That is a compound annual growth rate of -15.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 896.38M | 11.24% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | 2.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio Preventive Medicine | 1.18B |
| GeneReach Biotechnology | 1.13B |
| LabTurbo Biotech | 1.11B |
| BiOptic | 1.03B |
| Level Biotechnology | 1.02B |
| Meribank Biotech | 993.35M |
| TCI GENE | 971.03M |
| NatureWise Biotech & Medicals | 833.45M |